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Abstract Regulation of capacitative Ca2+ entry was studied in
two different multidrug resistance (MDR) protein (MRP1)
overexpressing cell lines, HT29col and GLC4/ADR. MRP1
overexpression was accompanied by a decreased response to
thapsigargin. Moreover, inhibition of capacitative Ca2+ entry by
D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol
(PDMP) was abolished in MRP1 overexpressing cells. Both
PDMP and the MRP1 inhibitor MK571 greatly reduced InsP3-
mediated 45Ca2+ release from intracellular stores in HT29 cells.
Again, these effects were virtually abolished in HT29col cells.
Our results point to a modulatory role of MRP1 on intracellular
calcium concentration ([Ca2+]i) homeostasis which may con-
tribute to the MDR phenotype.
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1. Introduction
Multidrug resistance (MDR) of cancer cells is often result-
ing in chemotherapy treatment failure. MDR can be conferred
by P-glycoprotein (Pgp) or MDR protein (MRP1), both mem-
bers of the ATP binding cassette (ABC) superfamily of trans-
porter proteins, which are responsible for enhanced drug ef-
£ux from cells [1,2]. Apart from (over)expression of ABC
transporters, other mechanisms may contribute to MDR,
e.g. reduced sensitivity to apoptotic induction [3^5]. In this
respect, the intracellular Ca2 concentration ([Ca2]i) is of
importance. Intracellular Ca2 is involved in regulation of
many cellular processes including contraction, secretion and
intracellular transport [6]. Moreover, [Ca2]i plays an impor-
tant role in both necrotic and apoptotic cell death [7]. Two
models have been proposed to explain the involvement of
Ca2 homeostasis in apoptosis [8]. In one, increases in
[Ca2]i due to depletion of intracellular stores and possibly
in£ux of Ca2 across the plasma membrane act as a signal for
apoptosis. This may lead to activation of Ca2-dependent
catabolic enzymes of the apoptotic machinery. In the second,
the emptying of intracellular Ca2 stores triggers apoptosis,
rather than increases in cytosolic Ca2. In this model, empty-
ing of Ca2 stores, such as endoplasmic reticulum and mito-
chondria, would result in loss of organelle membrane integ-
rity, leading to release of apoptotic e¡ectors. An important
role for the endoplasmic reticulum Ca2 homeostasis in the
apoptotic process is clearly indicated by the observations that
thapsigargin induces apoptosis through its persistent Ca2
pool depletion [9], while bcl-2 represses apoptosis by regulat-
ing endoplasmic reticulum-associated Ca2 £uxes [10,11]. In
the present study, we show that compared to the respective
parental cells, [Ca2]i regulation is altered in two entirely dif-
ferent MDR cell lines, HT29col colon carcinoma cells and
GLC4/ADR small cell lung carcinoma cells. These MDR cells
cell lines have in common their abundant overexpression of
MRP1, resulting from selection with di¡erent cytotoxic
agents, colchicine and doxorubicin, respectively. This indicates
that in addition to enhanced drug e¥ux by MRP1, this ABC
transporter may have a role in altering Ca2 homeostasis,
which in turn contributes to enhanced cell survival.
2. Materials and methods
2.1. Materials
Indo-1/AM was purchased from Molecular Probes (Eugene, OR,
USA). Ins(1,4,5)P3 and ATP were from Boehringer Mannheim
GmbH (Mannheim, Germany), 45CaCl2 (19.3 Ci/mol) was from
Amersham (Bercks, UK), D,L-threo-1-phenyl-2-decanoylamino-3-mor-
pholino-1-propanol (PDMP) was purchased from Matreya (Pleasant
Gap, PA, USA). Colchicine, thapsigargin and L-escin were from Sig-
ma (St. Louis, MO, USA). MK571 was a kind gift of Prof. Dr. A.W.
Ford-Hutchinson (Merck-Frost Inc., Kirkland, Canada).
2.2. Cell culture
The human colon adenocarcinoma cell line HT29 was cultured in
Dulbecco’s modi¢ed Eagle medium containing 25 mM glucose,
100 U/ml penicillin, 100 Wg/ml streptomycin and 10% (v/v) heat-in-
activated (56‡C, 30 min) fetal calf serum. Cells were seeded in a
density of 4U104 cells/cm2 and maintained in a water-saturated
atmosphere of 5% CO2/95% air at 37‡C. Medium was refreshed every
48 h and the culture was passed weekly in a 1:15 dilution. The in vitro
colchicine-selected, MRP1 overexpressing, Pgp-negative subline
HT29col was obtained and maintained as described [12]. The in vitro
doxorubicin-selected, MRP1 overexpressing, Pgp-negative subline
GLC4/ADR was cultured as described [13].
2.3. [Ca2+]i measurements
Intracellular Ca2 concentrations were determined as described pre-
viously [14,15]. After trypsinization, the cells were resuspended in
Hanks’ solution at 3^5U107 cells/ml for HT29 cells and 108 cells/ml
for GLC4 cells. The cells were loaded with 2 WM indo-1/AM for
30 min at room temperature in the dark. Under these conditions,
compartmentalization of the dye was minimal (8.2 þ 2.2%, n = 6 for
HT29 cells and 9.3 þ 3.6%, n = 4 for GLC4 cells) as judged from the
ratio of £uorescence signals obtained after selective permeabilization
of the plasma membrane (10 WM L-escin) and full permeabilization of
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the cells (1% Triton X-100). Then the cells were washed twice by
centrifugation and their £uorescence was measured in an Aminco^
Bowman spectrophotometer, using 106 cells/ml. Measurements were
performed at 22‡C, with a single excitation wavelength (349 nm) and a
dual emission wavelength (410 and 490 nm) at a frequency of 1 Hz.
Thapsigargin responses were measured at the plateau phase, which
represents capacitative Ca2 in£ux. In Ca2-free conditions, this pla-
teau was not reached (see also [14]).
2.4. 45Ca2+ £uxes in permeabilized cells
The cells were plated 48^72 h before the experiment in 6 well plates
(Costar) at a density of 5U106 cells/well. The experiments were car-
ried out at room temperature (22‡C), exactly as described previously
[16]. The 45Ca2 release was represented as the fractional loss of
45Ca2 per min in the mono-exponential phase, representing the
amount of 45Ca2 leaving the cell, normalized to the amount of la-
belled 45Ca2 present in the cell at that time.
2.5. Statistics
All experiments were performed in at least two di¡erent cell pas-
sages with ns 6. The results are presented as mean þ S.D. When nec-
essary, the statistical di¡erence was tested using Student’s t-test, con-
sidering P6 0.05 signi¢cant.
3. Results
3.1. Thapsigargin is less e¡ective in inducing [Ca2+]i increases
in MRP1 overexpressing cells
The two MRP1 overexpressing MDR cell lines HT29col and
GLC4/ADR did not di¡er in their basal [Ca2]i levels
(121 þ 14 nM, n = 60 and 46 þ 8 nM, n = 6, respectively), as
compared to the non-resistant parental cell lines HT29
(112 þ 15 nM, n = 60) and GLC4 (51 þ 7 nM, n = 6). Thapsi-
gargin induced dose-dependent increases in [Ca2]i in both
HT29 and HT29col cells (Fig. 1, left panel). However, thapsi-
gargin was less e¡ective in increasing [Ca2]i in MRP1 over-
expressing HT29col cells, at concentrations above 1038 M. A
similar pattern was observed in GLC4 cells, where thapsigar-
gin was again less e¡ective in increasing [Ca2]i in the MDR
cell line, GLC4/ADR (Fig. 1, right panel). These data show
that overexpression of MRP1 is accompanied by an alteration
of [Ca2]i regulation.
3.2. PDMP does not inhibit capacitative Ca2+ in£ux in MRP1
overexpressing cells
We have recently demonstrated [14] that PDMP, an inhib-
itor of glucosylceramide biosynthesis, has three di¡erent ef-
fects on [Ca2]i. (i) PDMP inhibited capacitative Ca2 entry,
(ii) PDMP elevated [Ca2]i under basal conditions and (iii)
PDMP released Ca2 from a thapsigargin-insensitive Ca2
store. Therefore, PDMP serves as a valuable tool to analyze
[Ca2]i regulation. Thus, we investigated if MRP1 overexpres-
sion, as observed in HT29col and GLC4/ADR cells, modi¢ed
the e¡ects of PDMP on [Ca2]i. In HT29col cells, the PDMP-
induced [Ca2]i increases above basal levels as well as the
Ca2 release from the thapsigargin-insensitive Ca2 store
were unchanged, as compared to the parental HT29 cells (Ta-
ble 1). In contrast, in HT29col cells, the inhibitory e¡ect of
PDMP on capacitative Ca2 entry was abolished (Fig. 2).
Again, this abolishment also occurred in MRP1 overexpress-
ing GLC4/ADR cells (Fig. 2).
Fig. 1. Dose^e¡ect response curves for thapsigargin in HT29 (left
panel) and GLC4 cells (right panel), in non-resistant parental cells
(a) and in cells overexpressing MRP1 (E), HT29col and GLC4/
ADR. The results are presented as the mean ( þ S.D.) maximal in-
crease over basal levels (n = 6), with a signi¢cance level of P6 0.05.
Fig. 2. Dose-dependent inhibition by PDMP of the thapsigargin
(1036 M)-elicited [Ca2]i increases in HT29 (left panel) and GLC4
cells (right panel). Measurements were performed in non-resistant
parental cells (a) and MRP1 overexpressing HT29col and GLC4/
ADR cells (E). The results are presented as the mean percentage
( þ S.D.) of the thapsigargin response (in nM) at 0 WM PDMP (see
Fig. 1), which was set at 100% (n = 6).
Table 1
E¡ect of PDMP on basal [Ca2]i and release from a thapsigargin-
insensitive store in HT29col cells
Maximal [Ca2]i
increase
Release from
thapsigargin-insensitive
Ca2 store
HT29 135 þ 26 48 þ 15
HT29col 119 þ 18 52 þ 12
E¡ects of PDMP on basal [Ca2]i in HT29 and HT29col cells are re-
ported as maximal increases above basal levels; PDMP-induced re-
lease of Ca2 from a thapsigargin-insensitive store in HT29 and
HT29col cells was measured as described [14]. The results are pre-
sented as the mean þ S.D. (n = 6).
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3.3. PDMP and MK571 do not inhibit InsP3-mediated 45Ca2
+
release in MRP1 overexpressing cells
In order to investigate the relation between the altered Ca2
homeostasis and the overexpression of MRP1 in HT29col cells,
we analyzed the e¡ect on [Ca2]i regulation of MK571. This is
an inhibitor of MRP1 function [17], which shares inhibitory
properties with PDMP on intracellular membrane transport
[14]. However, MK571 turned out to have a high intrinsic
£uorescence that interfered with measurement of [Ca2]i using
a variety of dyes (fura-2, indo-1, £uo-3). Therefore, we choose
to compare its e¡ects with those of PDMP on 45Ca2 £uxes in
permeabilized cells. Neither MK571 (50 WM) nor PDMP
(100 WM) modi¢ed basal 45Ca2 e¥ux. However, both drugs
largely inhibited the 45Ca2 release elicited by 5 WM InsP3 in
HT29 cells (Fig. 3). In contrast, in MRP1 overexpressing
HT29col cells, MK571 as well as PDMP were ine¡ective in-
hibitors of the InsP3-induced 45Ca2 e¥ux (Fig. 3).
4. Discussion
In the present work, we showed that overexpression of
MRP1 is accompanied by changes in [Ca2]i homeostasis.
This study was performed in two separate cell lines, both
characterized by overexpression of the ABC transporter pro-
tein MRP1. GLC4/ADR is a well-established cell line, which
was obtained from GLC4 small cell lung carcinoma cells by
selection with doxorubicin. We recently described a novel
MDR cell line, designated HT29col, which was selected from
the HT29 population with colchicine [12]. Resistance to col-
chicine was partly reversed by the MRP1 inhibitor MK571,
which indicated that other mechanisms of resistance were op-
erative in these cells. We showed that an altered sphingolipid
composition in HT29col cells may contribute to increased re-
sistance, since glucosylceramide levels were enhanced similarly
as observed in other MDR cells [12,18,19]. Moreover, such
changes in sphingolipid composition were also observed to
occur in GLC4/ADR cells. In the present study, a novel fea-
ture of both HT29col and GLC4/ADR cells was discovered,
which may contribute to the resistant phenotype. Although
the basal levels of [Ca2]i were unchanged in both MDR
cell lines, both MRP1 overexpressing cell lines displayed a
reduced capacitative Ca2 entry response to thapsigargin, as
compared to their non-resistant counterparts. Persistent Ca2
pool depletion by thapsigargin has been shown to result in
apoptosis in HepG2 cells [9]. Furthermore, overexpression of
the anti-apoptotic protein bcl-2 has been reported to maintain
endoplasmic reticulum Ca2 homeostasis and to reduce the
Ca2 response to thapsigargin [10,11]. Endoplasmic reticulum
Ca2 pool depletion is thus recognized to be of importance in
triggering apoptosis. On the other hand, it has been reported
that a reduced Ca2 entry can facilitate apoptosis [20]. In this
respect, the ability of PDMP to reduce capacitative Ca2 en-
try may add to its potential as an anti-cancer drug. A role for
glucosylceramide synthase inhibitors, like PDMP, in the treat-
ment of cancer has been documented previously [21,22]. Our
present results indicate an additional potential ‘target’ for this
drug. The inhibitory e¡ect of PDMP on InsP3-mediated
45Ca2 release was mimicked by MK571, an inhibitor of
MRP1 function. The e¡ects of both drugs were virtually abol-
ished in MRP1 overexpressing cells. Also the inhibitory e¡ect
of PDMP on thapsigargin-induced capacitative Ca2 in£ux
was abolished in MRP1 overexpressing cells. These data sug-
gest that Ca2 regulation is intimately linked to MRP1 ex-
pression and function. In parental, non-resistant HT29 and
GLC4 cells, a low expression of MRP1 occurs [12,13], which
is subject to e⁄cient inhibition by MK571 (and possibly
PDMP). MDR variants of these cells express high levels of
MRP1, which may exert strong control of Ca2 homeostasis.
Apparently, this favors a situation in which on the one hand
high cytosolic Ca2 levels, and on the other hand complete
emptying of intracellular Ca2 stores, are prevented. The lat-
ter is achieved by preventing inhibition of capacitative Ca2
in£ux, which is necessary to re¢ll organelle stores after release
from these stores is triggered. To our knowledge, this is the
¢rst study demonstrating the relationship between [Ca2]i ho-
meostasis and MRP1 expression.
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